Cimzia 2X200 MG/ML syringe kits
Ended Awarded Last action
- Contract number
- SPE2DR26F1WQW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,517
Award facts
- Contract value 100% obligated
- $16,516.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,516.91 to AmerisourceBergen Drug Corp for CIMZIA 2x200 mg/ml syringe kits, a biopharmaceutical product used in the treatment of inflammatory conditions. The order was issued on January 7, 2026, with an ultimate completion date of January 8, 2026, and represents a firm fixed-price contract with no set-aside designation. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's parent company, Cencora, Inc., which operates the pharmaceutical supply chain for federal medical procurement.
This delivery order is issued under Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of prescription medications, specialty pharmaceuticals, generic drugs, vaccines, and medical supplies to military healthcare programs worldwide, including the Defense Health Agency and other federal medical institutions. AmerisourceBergen's selection for this critical pharmaceutical distribution contract reflects its capability to compete on a full and open basis and efficiently fulfill federal medical supply requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F1WQW?
SPE2DR26F1WQW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F1WQW worth?
The government has obligated $16,517 on SPE2DR26F1WQW.
Is contract SPE2DR26F1WQW an order under another contract?
Yes. SPE2DR26F1WQW is a delivery order under SPE2DR25D3402, an indefinite delivery contract.
Was contract SPE2DR26F1WQW competed?
The extent of competition for SPE2DR26F1WQW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award